UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 66

of 'Treatment of relapsed or refractory chronic lymphocytic leukemia'

66
TI
Venetoclax (VEN) Monotherapy for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapsed after or Were Refractory to Ibrutinib or Idelalisib (abstract 637)
AU
Jones J,Choi MY,Mato AR,Furman RR,Davids MS
SO
Blood. 2015;
 
AD